Sam Blackman

Sam Blackman

Company: Day One Biopharmaceuticals Inc.

Job title: Head of Research and Development


Outlining the Landscape in Paediatric Glioma & Delving Into Recent Successes 9:15 am

Highlighting opportunities and challenges in developing therapeutics for elapsed or progressive paediatric low-grade glioma (pLGG). Navigating the dual challenges of a shifting landscape for response assessment criteria and changing views on minor response as evidence of clinical benefit. Targeting beyond the MAPK in paediatric glioma.Read more

day: Conference Day 1

Panel Discussion: How Can Investors & Companies Work Together to Save GBM Funding? 8:30 am

Addressing how to attract investment for novel therapies which are not yet clinically proven Understanding how to gain support for novel strategies, including combination therapy trials Comparing the two main sources of funding- public vs private funding Speakers To Be AnnouncedRead more

day: Conference Day 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.